TEVA PHARMACEUTICAL INDUSTRIES LIMITED Income (Loss) from Continuing Operations before Income Taxes, Domestic
TEVA PHARMACEUTICAL INDUSTRIES LIMITED (TEVJF) reported Income (Loss) from Continuing Operations before Income Taxes, Domestic of -$225.00 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-03.
Financial Statements › Income Statement › Pre-tax Income
us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic · last filed 2026-02-03
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED income (loss) from continuing operations before income taxes, domestic for fiscal 2025 was -$225.00M.
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED income (loss) from continuing operations before income taxes, domestic for fiscal 2024 was -$456.00M.
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED income (loss) from continuing operations before income taxes, domestic for fiscal 2023 was -$767.00M.
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED income (loss) from continuing operations before income taxes, domestic for fiscal 2022 was -$119.00M, a 194.44% decline from fiscal 2021.
| Period end | Income (Loss) from Continuing Operations before Income Taxes, Domestic 12 month |
|---|---|
| 2025-12-31 | -$225.00M 10-K · filed 2026-02-03 |
| 2024-12-31 | -$456.00M 10-K · filed 2026-02-03 |
| 2023-12-31 | -$767.00M 10-K · filed 2026-02-03 |
| 2022-12-31 | -$119.00M 10-K · filed 2025-02-05 |
| 2021-12-31 | $126.00M 10-K · filed 2024-02-12 |
| 2020-12-31 | $947.00M 10-K · filed 2023-02-10 |
| 2019-12-31 | $542.00M 10-K · filed 2022-02-09 |
| 2018-12-31 | $1.02B 10-K · filed 2021-02-10 |
| 2017-12-31 | $1.45B 10-K · filed 2020-02-21 |
| 2016-12-31 | $1.52B 10-K · filed 2019-02-19 |
| 2015-12-31 | $1.93B 10-K · filed 2018-02-12 |
| 2014-12-31 | $2.14B 20-F · filed 2017-02-15 |
| 2013-12-31 | $1.30B 20-F · filed 2016-02-11 |
| 2012-12-31 | $1.66B 20-F · filed 2015-02-09 |
| 2011-12-31 | $2.05B 20-F · filed 2014-02-10 |
| 2010-12-31 | $2.51B 20-F · filed 2013-02-12 |
| 2009-12-31 | $1.56B 20-F · filed 2012-02-17 |
| 2008-12-31 | $1.96B 20-F · filed 2011-02-15 |